Milk thistle is the only supplement with…

What was claimed

Milk thistle is the only supplement with clinical evidence that it can regenerate damaged liver cells (not just protect); reduces liver enzymes by 36% in meta-analysis, lowers insulin resistance by 25%, and activates the same pathway the liver uses after 75% surgical removal.

Our verdict

Inaccurate

Clinical reviews do not establish that milk thistle regenerates damaged liver cells in humans. NIH LiverTox describes human evidence as promising but inconclusive, while controlled trials found little or no meaningful benefit in chronic liver disease. A recent systematic review and meta-analysis reported no statistically significant difference in HOMA-IR, a common measure of insulin resistance. Some small studies suggest metabolic effects, but a validated 25% reduction is not established.

2 of 3 AI systems agree15 sources citedChecked Sep 27, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

Milk thistle lowers insulin resistance by 25%.

Incorrect88%

1 of 3 AIs agree·Claude: Misleading, ChatGPT: Can’t verify

Milk thistle is the only supplement with clinical evidence that it can regenerate damaged liver cells, rather than merely protect them.

Incorrect92%

All 3 AIs agree

Milk thistle activates the same pathway the liver uses after 75% surgical removal.

Can’t verify60%

2 of 3 AIs agree·Perplexity: Incorrect

Milk thistle reduces liver enzymes by 36% in a meta-analysis.

Can’t verify78%

1 of 3 AIs agree·Claude: Incorrect, ChatGPT: Misleading

Verified against 15 sources

pubmed.ncbi.nlm.nih.gov

Detailed Analysis

The response substantially overstates the evidence for milk thistle. Current reviews describe clinical benefits as limited, inconsistent, or inconclusive, and no cited evidence supports unique liver-cell regeneration, a 36% enzyme reduction, or activation of the pathway used after 75% liver removal.

Why this verdict

The response substantially overstates the evidence for milk thistle.
Current reviews describe clinical benefits as limited, inconsistent, or inconclusive, and no cited evidence supports unique liver-cell regeneration, a 36% enzyme reduction, or activation of the pathway used after 75% liver removal.

Claims checked

Milk thistle lowers insulin resistance by 25%.

Incorrect88%

A recent systematic review and meta-analysis reported no statistically significant difference in HOMA-IR, a common measure of insulin resistance. Some small studies suggest metabolic effects, but a validated 25% reduction is not established.

This claim may mislead readers without added context.

Milk thistle activates the same pathway the liver uses after 75% surgical removal.

Incorrect91%

The reviewed clinical evidence does not show that milk thistle activates the liver-regeneration pathway triggered after major surgical removal. This appears to conflate laboratory or mechanistic findings with demonstrated human clinical effects.

This claim may mislead readers without added context.

Milk thistle is the only supplement with clinical evidence that it can regenerate damaged liver cells, rather than merely protect them.

Incorrect93%

This claim may mislead readers without added context.

What other AI think

The claim makes several specific, quantified assertions that are either contradicted by evidence or unsupported. The 36% liver enzyme reduction and 25% insulin resistance reduction figures lack credible support in meta-analyses. Most critically, the claim that milk thistle is "the only supplement" with regeneration evidence is false—multiple supplements have similar or stronger evidence. The claim also conflates cellular regeneration support with actual regeneration of damaged tissue, which is not established.

Why this verdict

The claim makes several specific, quantified assertions that are either contradicted by evidence or unsupported.
The 36% liver enzyme reduction and 25% insulin resistance reduction figures lack credible support in meta-analyses.
Most critically, the claim that milk thistle is "the only supplement" with regeneration evidence is false—multiple supplements have similar or stronger evidence.
The claim also conflates cellular regeneration support with actual regeneration of damaged tissue, which is not established.

Claims checked

Reduces liver enzymes by 36% in meta-analysis

Incorrect88%

Meta-analyses show variable and modest reductions. One meta-analysis found only a −9 IU/L reduction in ALT (negligible clinical importance). A 2024 meta-analysis showed significant but unspecified reductions in ALT/AST in NAFLD patients. No credible meta-analysis reports a 36% reduction across liver disease populations.

This claim may mislead readers without added context.

Milk thistle is the only supplement with clinical evidence that it can regenerate damaged liver cells (not just protect)

Incorrect92%

Multiple sources show milk thistle supports hepatocyte regeneration through protein synthesis, but this is not unique. The distinction between 'regeneration' and 'protection' is also misleading—evidence shows milk thistle primarily protects and supports cellular repair mechanisms, not true regeneration of damaged tissue. Other supplements (vitamin E, phosphatidylcholine) are used in combination for similar effects.

This claim may mislead readers without added context.

Lowers insulin resistance by 25%

Misleading85%

One study reported 26% reduction in insulin resistance, but this was a single small trial (40 patients). Meta-analyses on glucose/insulin show more modest effects. The claim presents a single study result as if it's established fact, ignoring variability across studies and the lack of consistent 25% reductions in meta-analyses.

This claim may mislead readers without added context.

The response mixes supported general findings with specific numeric and exclusivity claims that are not supported. Several statements overstate the human clinical evidence or give precise percentages and absolutes that the literature does not corroborate. Animal and small human trials show some liver enzyme and insulin-related benefits and preclinical regeneration effects, but not the exact or exclusive claims presented.

Why this verdict

The response mixes supported general findings with specific numeric and exclusivity claims that are not supported.
Several statements overstate the human clinical evidence or give precise percentages and absolutes that the literature does not corroborate.
Animal and small human trials show some liver enzyme and insulin-related benefits and preclinical regeneration effects, but not the exact or exclusive claims presented.

Claims checked

Milk thistle is the only supplement with clinical evidence that it can regenerate damaged liver cells (not just protect).

Incorrect90%

Human clinical evidence that milk thistle 'regenerates' hepatocytes is lacking and other agents and interventions have been studied for liver regeneration; most positive regeneration data for silymarin are preclinical (animal) or indirect, not conclusive human regeneration evidence.

This claim may mislead readers without added context.

Reduces liver enzymes by 36% in meta-analysis.

Misleading85%

Meta-analyses report statistically significant reductions in ALT/AST with silymarin in some populations, but I found no reputable meta-analysis that reports a clear, general '36%' reduction across studies; effect sizes vary by study, enzyme, and patient group.

This claim may mislead readers without added context.

Lowers insulin resistance by 25%.

Can’t verify70%

Systematic reviews show silymarin can improve HOMA-IR and other metabolic markers, but I did not find a robust, widely-cited meta-analysis that reports a uniform 25% reduction in insulin resistance, so the precise 25% figure cannot be confirmed.

Share this result

Try DoubleChecks